Associations of perceived helpfulness of depression treatment modality with symptom severity and substance use disorder

抑郁症治疗方式的感知有效性与症状严重程度和物质使用障碍之间的关联

阅读:1

Abstract

BACKGROUND: Mental health treatment use remains low despite increasing major depressive episodes (MDE), suicidality, and substance use disorders (SUD). AIMS: To examine the associations of perceived treatment helpfulness with clinical characteristics (MDE, suicidality, and SUD) and treatment modality (medication, counseling/other treatment [COT], and both treatment [MCOT]). METHODS: We used the 2022 and 2023 U.S. National Survey on Drug Use and Health data on adult depression treatment users (N = 10,221) and multinomial and generalized ordinal logistic regression models. RESULTS: Among treatment users, 15% used medication only, 25% used COT only, and 60% used MCOT. Overall, 60% of medication users and 47% of COT users perceived their respective treatments as “a lot” or “extremely” helpful. MDE and suicidality were associated with a higher likelihood of using COT only and/or MCOT. Both MDE and suicidality were associated with lower odds of perceiving treatment as helpful among medication users (OR =  0.47, 95% CI = 0.39–0.57 for MDE; OR =  0.78, 95% CI  =  0.66–0.91 for suicidality) as well as COT users (OR  = 0.67, 95% CI =  0.56–0.80 for MDE; OR =  0.82, 95% CI  = 0.70–0.97 for suicidality). Co-occurring alcohol and drug use disorders were also associated with lower odds of perceived helpfulness among COT users. The use of both medication and COT was associated with higher odds of perceiving either modality as helpful. These patterns did not differ meaningfully for individuals with MDE. CONCLUSIONS: The lower perceived treatment helpfulness among individuals with complex clinical presentations underscores the need for more intensive, personalized, and sustained interventions. Comparison between treatment recipients’ perceived helpfulness and objective clinical effectiveness is also needed. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s44192-026-00370-2.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。